James I. Zirkle

James I. Zirkle

James Zirkle is an associate in the Intellectual Property Group and has represented clients in patent litigations involving various technologies, including wireless communications and medical devices. In addition, he also has experience preparing petitions for inter partes review of patents before the United States Patent and Trademark Office.

Subscribe to all posts by James I. Zirkle

FDA Issues Draft Guidance for Drug and Device Information on Social Media

The Food and Drug Administration (“FDA”) recently issued two draft guidance documents relating to the use of Twitter and other social media by drug and medical device companies. Emphasizing that companies must give a balanced presentation of their products, the Agency stated that companies must provide risk information along with any benefit information within a tweet or similar promotional message.… Continue Reading

LexBlog